Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY 4.0Cells

hiPSC Extract Attenuates Senescence-Associated Phenotypes in AB-MSCs In Vitro

  1. 1Department of the First Outpatient, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing 210000, China
  2. 2Department of Prosthodontics, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing 210000, China
  3. 3Digital Engineering Center of Stomatology, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing 210000, China

Abstract

Background: Bone marrow mesenchymal stromal cells (BMSCs) are widely used as seed cells in bone tissue engineering. However, sufficient cell quantities for effective engineering typically require prolonged in vitro expansion of BMSCs, which can lead to cellular senescence after excessive subculturing. Objective: This study aimed to investigate the effects of human induced pluripotent stem cell (hiPSC) extract on replicative senescence, clonogenic ability, proliferation-associated characteristics, and osteogenic differentiation capacity of human alveolar bone-derived mesenchymal stromal cells (AB-MSCs). Methods: AB-MSCs were isolated from alveolar bone fragments discarded during dental implant surgery. Cells were divided into three experimental groups: P3 AB-MSCs (Young), P10 AB-MSCs (senescence-associated, YRS), and P10 AB-MSCs treated with hiPSC extract (YRSiE). Senescence markers, clonogenic ability, proliferation-associated characteristics, osteogenic potential, mRNA sequencing and pathway-related expression changes were compared among groups. Small RNA sequencing on hiPSCs and AB-MSCs with qRT-PCR validation were performed to identify candidate miRNAs in hiPSC extract that were differentially expressed in this setting. Results: In the presence of hiPSC extract, senescent AB-MSCs showed altered morphology, a lower proportion of β-galactosidase-positive cells, higher Ki67 expression, and lower expression of the senescence-associated genes and proteins P16 and P21. Treated senescent AB-MSCs also showed higher proliferation-associated metabolic activity, clonogenicity, and osteogenic differentiation than untreated senescent cells. Pluripotency-related genes (NANOG, OCT-4) and osteogenic markers (ALP, RUNX2, OCN) were higher in the treated group. qRT-PCR validation of small RNA sequencing data showed that miR-514a-3p, miR-582-5p and miR-520c-3p were upregulated in senescent AB-MSCs after hiPSC extract treatment. Concurrently, pathway enrichment and pathway-related expression changes were consistent with an association with the NF-κB pathway. Conclusion: In this in vitro study, hiPSC extract attenuates senescence-associated phenotypes in AB-MSCs, and the observed transcriptional and pathway-related expression changes were consistent with NF-κB pathway enrichment, with the identified miRNAs upregulated in treated cells and previously reported to target NF-κB pathway components. However, these mechanisms require further validation.

Related

  1. AICAR attenuates senescence-associated phenotypic remodeling of liver sinusoidal endothelial cells via the AMPK–SIRT1/p53 axis in CCl₄-induced liver fibrosis
    Yi-meng Wang, Zi-xuan Zhao, Tao Li +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  2. Plant‐Derived Senolytic Ingredient, Camellia sinensis Root Extract, Ameliorates Skin Aging‐Associated Phenotypes
    Sunyoung Park, Siyoung Cho, Daejin Min +5
    Experimental dermatologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Dissecting the reciprocal association between cytoskeletal mechanics and senescence-associated phenotypes in human dermal fibroblasts
    Han Tang, Ruonan Qian, Ning Wang +5
    Frontiers in physiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  4. Verbascoside suppresses malignant phenotypes and induces senescence-associated changes in glioblastoma cells associated with Skp2 downregulation
    Jingjing Wei, Baoxin Ren, Rui Zhang +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  5. Phenolic-Rich Aronia melanocarpa (cv. Nero) Extract Attenuates Doxorubicin-Induced Nephrotoxicity Associated with Reduced Oxidative Stress, Inflammation, and Endoplasmic Reticulum Stress
    Meltem Arıkan Malkoç, Serap Özer Yaman, Hüseyin Çınkılıç +4
    MoleculesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
BibTeX
@article{pan2026hipsc,
  title = {{hiPSC Extract Attenuates Senescence-Associated Phenotypes in AB-MSCs In Vitro}},
  author = {Yuanyuan Pan and Lumiao Zhang and Rongyuan Zhu and Fangfang Sun and Guofeng Wu},
  journal = {Cells},
  year = {2026},
  month = oct,
  doi = {10.3390/cells15211965},
  url = {https://www.mdpi.com/2073-4409/15/21/1965},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - hiPSC Extract Attenuates Senescence-Associated Phenotypes in AB-MSCs In Vitro
AU  - Yuanyuan Pan
AU  - Lumiao Zhang
AU  - Rongyuan Zhu
AU  - Fangfang Sun
AU  - Guofeng Wu
PY  - 2026
DA  - 2026/10/28
JO  - Cells
DO  - 10.3390/cells15211965
UR  - https://www.mdpi.com/2073-4409/15/21/1965
AB  - Background: Bone marrow mesenchymal stromal cells (BMSCs) are widely used as seed cells in bone tissue engineering. However, sufficient cell quantities for effective engineering typically require prolonged in vitro expansion of BMSCs, which can lead to cellular senescence after excessive subculturing. Objective: This study aimed to investigate the effects of human induced pluripotent stem cell (hiPSC) extract on replicative senescence, clonogenic ability, proliferation-associated characteristics, and osteogenic differentiation capacity of human alveolar bone-derived mesenchymal stromal cells (AB-MSCs). Methods: AB-MSCs were isolated from alveolar bone fragments discarded during dental implant surgery. Cells were divided into three experimental groups: P3 AB-MSCs (Young), P10 AB-MSCs (senescence-associated, YRS), and P10 AB-MSCs treated with hiPSC extract (YRSiE). Senescence markers, clonogenic ability, proliferation-associated characteristics, osteogenic potential, mRNA sequencing and pathway-related expression changes were compared among groups. Small RNA sequencing on hiPSCs and AB-MSCs with qRT-PCR validation were performed to identify candidate miRNAs in hiPSC extract that were differentially expressed in this setting. Results: In the presence of hiPSC extract, senescent AB-MSCs showed altered morphology, a lower proportion of β-galactosidase-positive cells, higher Ki67 expression, and lower expression of the senescence-associated genes and proteins P16 and P21. Treated senescent AB-MSCs also showed higher proliferation-associated metabolic activity, clonogenicity, and osteogenic differentiation than untreated senescent cells. Pluripotency-related genes (NANOG, OCT-4) and osteogenic markers (ALP, RUNX2, OCN) were higher in the treated group. qRT-PCR validation of small RNA sequencing data showed that miR-514a-3p, miR-582-5p and miR-520c-3p were upregulated in senescent AB-MSCs after hiPSC extract treatment. Concurrently, pathway enrichment and pathway-related expression changes were consistent with an association with the NF-κB pathway. Conclusion: In this in vitro study, hiPSC extract attenuates senescence-associated phenotypes in AB-MSCs, and the observed transcriptional and pathway-related expression changes were consistent with NF-κB pathway enrichment, with the identified miRNAs upregulated in treated cells and previously reported to target NF-κB pathway components. However, these mechanisms require further validation.
SN  - 2073-4409
ER  -